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Structured Abstract 
Background: The pre-formed silo (PFS) is increasingly used in the management of gastroschisis but 
its benefits remain unclear. We performed a systematic review and meta-analysis of the literature 
comparing use of a PFS with alternate treatment strategies. 
Methods: Studies comparing the use of a PFS with alternate strategies were identified and data 
extracted. The primary outcome measure was length of time on a ventilator. Mean difference (MD) 
between continuous variables and 95% confidence intervals were calculated.  Risk difference (RD) 
and 95%CI were determined for dichotomous data. 
Results: Eighteen studies, including one randomised controlled trial, were included. Treatment 
strategy and outcome measures reported varied widely. Meta-analysis demonstrated no difference 
in days of ventilation but a longer duration of parenteral nutrition (PN) requirement (MD 6.4 days 
[1.3, 11.5]; p=0.01) in infants who received a PFS. Subgroup analysis of studies reporting routine use 
of a PFS for all infants demonstrated a significantly shorter duration of ventilation with a PFS (MD 2.2 
days [0.5, 3.9]; p=0.01) but no difference in duration of PN requirement. Other outcomes were 
similar between groups. 
Conclusion: The quality of evidence comparing PFS with alternate treatment strategies for 
gastroschisis is poor. Only routine use of PFS is associated with fewer days on a ventilator compared 
with other strategies. No strong evidence to support a preference for any strategy was 
demonstrated. Prospective studies are required to investigate the optimum management of 
gastroschisis. Standardised outcome measures for this population should be established to allow 
comparison of studies. 
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Introduction 
The optimum surgical treatment of infants born with gastroschisis remains unclear. Following 
Watkins’s first report of primary closure of the abdominal wall in 1943,[1] the principle of surgical 
treatment has remained returning the eviscerated abdominal organs to the abdomen as soon as 
possible whilst avoiding the potential complications of viscero-abdominal disproportion (i.e. 
abdominal compartment syndrome and/or need for prolonged ventilation).  Traditionally, surgeons 
have aimed to achieve primary abdominal wall closure whenever safe and, if not, to fashion a 
surgical ‘silo’ to allow gradual visceral reduction prior to definitive abdominal wall closure. 
 
Over the past 20 years a pre-formed silo (PFS) comprising a transparent silastic bag fitted with a 
spring loaded ring has been introduced and its use adopted widely. This has led to a change of 
practice such that many units now use placement of a PFS on the neonatal intensive care unit 
without general anaesthesia (GA) as an alternate to attempted emergency abdominal wall closure 
under GA. This is followed by gradual reduction of the abdominal contents and delayed abdominal 
wall closure in a semi-elective setting. Recent national and international surveys confirm the uptake 
of this technique [2, 3]. Outcomes of infants treated with a PFS have been reported by a number of 
institutions and in some instances compared with those of infants treated with primary closure. 
Several reports describe the benefits of using a PFS for both patient and surgeon and propose their 
routine use [4, 5]. However, other authors have highlighted potential pitfalls with the use of the PFS 
[6, 7]. As a result, the precise role for the PFS in the treatment of infants with gastroschisis remains 
unclear. 
 
The aim of this study was to evaluate current evidence comparing the use of a PFS with alternate 
treatment strategies in infants with gastroschisis. We performed a systematic review of the existing 
literature. We also aimed to perform a meta-analysis of available data by applying strict eligibility 
criteria to ensure comparability. 
 
Methods 
We searched Medline, Embase and the Cochrane controlled trials register from inception to July 
2014 using the terms ‘gastroschisis’, ‘gastroschisis AND silo’, ‘preformed silo’ and ‘silastic silo’. 
Abstracts of the unfiltered literature were reviewed and full text versions of selected publications 
were assessed for inclusion. Reference lists of these publications were also checked to identify 
additional relevant reports. The literature search, assessment for inclusion and data extraction were 
performed independently by 3 reviewers and disagreements resolved by consensus. 
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Studies were selected for inclusion in the review if they reported comparative outcomes between 
infants treated with a PFS and infants treated with an alternate treatment strategy. Studies were 
excluded if they reported a cohort of infants treated only with a PFS with no comparative group, 
reported a cohort of infants treated with a PFS grouped with infants treated with another treatment 
strategy such as a hand-sewn silo, originated from a non-developed country or were not in English. 
For infants treated with a PFS no selection was made on the basis of final technique of abdominal 
wall closure (i.e. all were included). 
 
All outcomes were selected a priori. The primary outcome measure was time on a ventilator. 
Secondary outcomes were number of infants never ventilated, time on parenteral nutrition (PN), 
time to achieve full enteral feeds, length of hospital stay, incidence of necrotising enterocolitis, 
number of unplanned re-operations, infectious complications, mortality and occurrence of ventral 
hernia following repair. 
 
Where studies reported outcomes of more than 2 treatment types (e.g. PFS, primary closure and 
staged closure using a hand-sewn silo) we selected the group undergoing primary closure as the 
comparator group and excluded the other group(s) from the analysis. 
 
Data were extracted and entered into Review Manager (v5.1, The Cochrane Collaboration) and 
meta-analysis was performed using a random effects model due to variation in study design and 
reporting. Summary statistics for continuous variables are reported as mean difference (MD) with 
95% confidence interval (95%CI) and dichotomous variables as risk difference (RD) with 95%CI in 
order to allow inclusion of studies with zero events.[8] An I2 statistic for heterogeneity was 
calculated for each pooled dataset. For the purposes of meta-analysis continuous data are required 
to be in the format of mean and standard deviation (SD). For studies that only reported median and 
range, mean and SD were estimated using validated formulae specifically developed for this purpose 
[9]. 
 
We anticipated a large proportion of the data available would arise from retrospective cohort 
studies. Our a priori intention was therefore to perform subgroup analysis that included only studies 
reporting pre-planned management strategies for gastroschisis. Only studies that used an intended 
policy to treat all infants routinely with a PFS unless clinically contra-indicated were included in this 
subgroup analysis. If it was unclear whether such a policy existed then it was assumed that none did 
and the study was excluded from this subgroup analysis. The subgroup analysis therefore allows a 
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comparison of outcomes based on an ‘intention to treat’ all infants in the PFS group with a PFS 
unless clinically contra-indicated. 
 
 
Results 
Search results 
One-thousand, five-hundred and sixty-seven articles were identified using the specified search 
criteria and their abstracts reviewed. Following application against our inclusion criteria, 1440 were 
excluded on the basis of their abstract alone and the full text of 127 publications was scrutinised. 
One hundred and seven of these were subsequently excluded as they did not report a comparative 
group, did not use a PFS, or did not report outcomes from a group all treated with a PFS. Two further 
reports were excluded to avoid duplication of patients; the study by Bonnard et al [10] was excluded 
as it reported patients included in another report during an overlapping time period from the same 
centre [11] and the study by Allotey et al [4] was excluded as all patients included were 
subsequently included in a larger report from the same centre 7 years later by Charlesworth et al 
[12]. The remaining 18 publications were included in this systematic review. Characteristics of 
included studies are shown in Table 1. Of these 18, four met the criteria for inclusion in the subgroup 
analysis (Figure 1). 
 
There was one prospective randomised controlled trial (RCT) comparing use of a PFS with primary 
fascial closure [11]. This was a multi-centre study which recruited 54 infants over a 5½ year period 
and was terminated prior to full recruitment due to low accrual rate. Seventeen of the 18 included 
studies were cohort studies including 3 reporting data collected from multiple centres during 
national cohort studies on gastroschisis [13-15]. Two of these report separate outcomes from the 
same dataset obtained from a national cohort study in the United Kingdom [13, 14]. To avoid 
duplication we extracted data exclusively from one or other of these reports for each outcome 
measure. The single RCT and 3 other studies met the criteria for inclusion in the intention to treat 
analysis; all infants in these reports who received a PFS did so as part of a pre-planned management 
strategy (either as part of an institutional policy [5, 12, 16] or as part of a RCT [11]) to treat all infants 
reported as receiving a PFS with a PFS unless clinically contra-indicated. 
 
Outcome measures reported by individual studies varied. The outcomes most frequently reported 
were number of days of ventilation, time to achieve full enteral feeds and length of stay. It was 
possible to retrieve data on the primary outcome measure (number of days of ventilation) from 8 of 
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the 18 included papers. Other clinically important outcomes including incidence of necrotising 
enterocolitis, need for further surgery and mortality were variably reported. 
 
Patients and treatment received 
In total 1516 patients are included in this review of whom 666 were treated with a PFS. The 
intention to treat subgroup analysis includes data from 318 patients of whom 133 were treated with 
a PFS. There were no significant differences between infants treated with a PFS and those treated 
with an alternate treatment strategy in gestational age (MD 0.05 weeks [-0.3, 0.41]; p=0.77), birth 
weight (MD 0.01 kg [-0.09, 0.1]; p=0.94) or gender distribution (difference in proportion of males 2% 
[-9%, 13%]; p=0.67). 
 
All infants included in the PFS group were treated with a PFS. The comparator group consists of 
infants treated with an alternate strategy including predominantly primary closure with GA, but also 
primary closure at the cotside without GA, and attempted primary closure with a ‘handsewn silo’ or 
PFS if primary closure could not be achieved (Table 1). In the intention to treat subgroup analysis, 
the comparator group was attempted primary closure under general anaesthesia with formation of 
either a handsewn silo [5, 12, 16] or insertion of a PFS [11] if primary closure was not possible. 
 
Infants with complex gastroschisis as defined by the criteria of Molik [17] were excluded in 6 studies 
whilst others included both simple and complex cases (Table 1). In the intention to treat subgroup 
analysis 3 studies included all infants with simple and complex gastroschisis [5, 11, 16] and 1 study 
specifically excluded infants with atresia, gut infarction or short bowel syndrome [12]. It was not 
possible to perform an additional subgroup analysis for simple and complex gastroschisis as 
outcome data were not reported by severity of disease in the majority of studies. 
 
Quantitative analysis of outcomes 
The primary outcome of number of days of ventilation was reported in 8 studies (641 patients). In 
the overall analysis there was no statistically significant difference in number of days of ventilation 
between infants treated with a PFS and alternate techniques (Figure 2A). However in the intention-
to-treat analysis, use of PFS was associated with a significant reduction in days of ventilation of 2.2 
days (0.47, 3.93); p=0.01 (Figure 2B). There was significant heterogeneity between studies in the 
overall analysis (I2=70%, p=0.002) but not in the subgroup analysis (I2=35%, p=0.2). Five studies 
reported the proportion of infants in each group who were never mechanically ventilated. None of 
these were in the intention-to-treat subgroup analysis. There was no difference in the proportion of 
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infants never ventilated in each group and significant heterogeneity between studies likely as a 
result of differing indications for use of the PFS in different settings (Figure 2C). 
 
Overall duration of PN was significantly longer in infants treated with a PFS (MD 6.38 days [1.3, 
11.46]; p=0.01) whereas time to reach full enteral feeds and length of stay were similar between 
groups (Figure 3). In the intention to treat subgroup analysis, duration of PN, time to reach full 
enteral feeds and length of stay were all similar between infants treated with a PFS and those with 
an alternate strategy (Figure 4). There was again significant heterogeneity between results of 
individual studies in both the overall and intention-to-treat subgroup analyses. 
 
All other outcomes were similar between infants treated with a PFS and those with an alternate 
strategy in the main analysis and subgroup analysis (Table 2) with the exception of need for 
unplanned re-operation and occurrence of ventral hernia. In the intention-to-treat analysis fewer 
infants treated with a PFS required an unplanned operation and in the overall analysis fewer infants 
treated with a PFS developed a ventral hernia following repair. No study in the subgroup analysis 
reported incidence of ventral hernia. 
 
Discussion 
This systematic review aimed to determine comparative outcomes for infants with gastroschisis 
treated with either a PFS or alternate treatment strategy. Overall the quality of evidence currently 
available in this field is poor; to date only one randomised controlled trial has been reported [11]. 
Whilst meta-analysis is typically aimed as synthesising evidence obtained in RCTs, where such 
studies are lacking, data obtained from studies using alternate methodology may be valuable. The 
majority of studies included were retrospective cohort studies which compared outcomes between 
PFS and alternate strategies either contemporaneously or in some cases between separate defined 
time periods. In several studies the indication for treatment with a PFS or alternate strategy was 
poorly defined, if at all. As a result there is significant potential for both treatment and selection 
biases to influence the findings of this analysis. 
 
The influence of bias is one of the difficulties encountered when combining data from multiple 
retrospective series. The key source of bias in this review is indication for treatment received 
resulting in significant selection bias. For instance it is possible that infants with least abdomino-
visceral discrepancy were treated with primary closure and those with greater discrepancy received 
a PFS.  Alternatively in some studies infants who received a PFS were allocated to that treatment on 
the basis that they had failed treatment by an alternate (preferred) method. This bias likely has an 
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effect on the findings of this meta-analysis. We considered from the outset the value of including all 
comparative series in this meta-analysis compared to focussing only on those reports using a pre-
planned management strategy. In the interest of greater data transparency we included all reports 
and additionally performed a pre-planned subgroup analysis. Studies were selected for inclusion in 
the subgroup analysis if they reported data from series where there was a pre-planned strategy, 
either at an institutional level or as part of a RCT, to use a PFS for all infants reported in the PFS 
group unless clinically contra-indicated. 
 
Whilst this approach has the advantage of reducing the impact of selection bias from the group 
treated with a PFS, it should be noted that it also introduces selection bias in some cases to the 
comparator group as some of those infants were by definition not suitable for treatment with a PFS. 
The sole RCT [11] reports two groups without selection bias although it could be claimed that 
selection bias may exist at the level of trial recruitment as only a small proportion of eligible patients 
were recruited. It may be that surgeons recruiting to the trial maintained a degree of bias and that 
this influenced their decision of whether to offer the trial to their patients or not. 
 
The quantitative findings of this review suggest that clinically important outcomes are similar 
between infants who received a PFS and those treated with an alternate treatment strategy. We 
selected days of ventilation as the primary outcome measure as a surrogate marker of increased 
abdominal pressure, a phenomenon that may be avoided when using a PFS. Whilst factors other 
than abdominal pressure may influence need for ventilation, the absence of a sudden increase in 
intra-abdominal pressure that can be achieved with a PFS when compared to primary closure in 
particular has been cited as a potential advantage of the PFS[16]. Further we believe that days of 
ventilation is an important outcome measure in a critical care setting. Overall there was no 
statistically significant difference in days of ventilation between groups. The proportion of infants 
never ventilated, time to achieve full enteral feeds and total length of stay were also similar 
between groups, although duration of parenteral nutrition (PN) was significantly shorter in infants 
treated with an alternate treatment strategy than with a PFS. Longer duration of PN in infants 
treated with a PFS has been reported by a number of the individual studies contributing to this 
review [18-20]. This may be explained by the inherent added time taken to achieve abdominal wall 
closure in infants treated with a PFS which contributes to a delay in starting enteral feeds and overall 
a longer requirement for PN. 
 
In contrast to the overall findings, in the intention to treat subgroup analysis use of a PFS was 
associated with a shorter duration of ventilation. This demonstrates that when a PFS is used as a 
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preferred treatment strategy or in a randomised trial, duration of ventilation can be reduced. Indeed 
many infants included in the included studies never required ventilatory support.  Unfortunately, 
none of the studies eligible for inclusion in the subgroup analysis formally reported this figure 
thereby precluding quantitative meta-analysis of this outcome. Additionally, the association 
between PFS use and increased duration of PN seen in the overall analysis is not seen in the 
subgroup analysis. We believe that selection bias is the most likely cause of these two differences 
and justifies our use of a pre-planned subgroup analysis. 
 
A number of authors have commented on the proposed benefits or disadvantages of the PFS 
compared to other strategies [5, 12, 16, 18]. Despite collating the largest body of comparative data 
to date, all remaining outcomes were similar between the groups in both the overall analysis and 
subgroup analysis with the exception of the number of unplanned re-operations and development of 
ventral hernia (Table 2). Fewer unplanned operations were reported in infants treated with a PFS 
and this difference was statistically significant in the intention-to-treat analysis. Within the intention 
to treat analysis these operations were for necrotising enterocolitis, intestinal perforation, stricture 
or obstruction.[5, 12, 16]. Particular concern has been raised that use of a PFS may be associated 
with bowel necrosis within the PFS [7]. Bowel necrosis may also be due to high abdominal pressure 
after primary closure. Both the overall and the intention to treat analysis did not reveal any 
significant difference in bowel necrosis with PFS or alternate strategy. Regarding the development of 
ventral hernia following repair, infants treated with a PFS had a lower incidence of ventral hernia in 
the overall analysis. It should be noted there was significant heterogeneity in individual study 
outcomes in this analysis which likely reflects different abdominal wall closure (as opposed to 
reduction) techniques between studies. We believe the final technique of abdominal wall closure is 
likely a better predictor of later herniation than the technique of visceral reduction. 
 
The results of this review and meta-analysis require careful interpretation in terms of implications 
for clinical practice. The association between PFS use and increased duration of PN in the overall 
analysis suggests that infants treated with a PFS may be being subjected to an unnecessarily long 
duration of PN dependency. We speculate that a delay in commencing enteral feeds whilst waiting 
for abdominal wall closure may be responsible for this difference. Whether such a delay is strictly 
necessary has never been formally tested to our knowledge. Conversely, a treatment strategy of 
primary fascial closure may achieve a shorter duration of PN at the expense of longer duration of 
ventilation with its associated risks and cost implications. Which of these detriments is preferable is 
not known. 
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Whilst we selected days of ventilation as the primary outcome for this review it is unclear which of 
the outcome measures reported is of greatest importance to clinicians and/or parents. For instance, 
whilst some may view a reduction in days of ventilation of greatest importance others may place 
greater emphasis on duration of PN or total length of stay. No doubt the range of outcomes 
reviewed here encompasses the majority of those felt to be important to clinicians. Whether parents 
and indeed other stakeholder groups consider these to be important is unknown. The importance of 
this is in selecting the right outcomes by which to measure success or otherwise of any treatment 
intervention known as a core outcome set. To our knowledge no such core outcome set exists for 
infants with gastroschisis. 
 
This study highlights the lack of high quality evidence regarding the optimum treatment strategy for 
infants with gastroschisis. Whilst it would be easy to propose a RCT as the optimal solution to this 
controversy, the difficulties in designing a RCT that is acceptable to both surgeons and parents 
should not be underestimated as Pastor and colleagues’ experience demonstrates [11]. In particular, 
surgeons would have to overcome the prejudice formed during their previous accumulated clinical 
experience of treating infants with gastroschisis. The widespread adoption of the PFS with its clear 
logistical advantages over emergent primary fascial closure is another obstacle. The PFS may be 
placed by a suitably trained trainee at any time of day thereby avoiding out-of-hours emergency 
operating by a consultant/attending surgeon.  It is likely therefore that the PFS is here to stay. 
However by casting aside such prejudices we do believe it possible to perform a robust investigation 
of the available treatment strategies for these infants. We therefore favour further study in the form 
of prospective, multicentre, protocol driven collaboration. 
 
Recently Kunz and colleagues have presented the findings of a similar piece of work comparing 
outcomes between primary closure and staged closure using any type of silo (including both PFS and 
handsewn silo). There are several important differences between Kunz’s review and ours which are 
relevant. Firstly Kunz and colleagues only included reviews that compared staged closure with 
primary fascial closure. Any other closure technique such as immediate bedside reduction followed 
by ‘sutureless’ or ‘plastic’ closure was not included in their review. Secondly they grouped infants 
treated with a PFS together with infants treated with a traditional handsewn silo. It is our 
observation from the literature and our communication with paediatric surgeons worldwide that the 
PFS is now used in preference to a handsewn silo almost universally (where available and affordable) 
and that many surgeons perform immediate reduction and plastic closure if the clinical situation 
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permits. Our review focuses entirely on the controversy surrounding the use of the PFS versus all of 
the alternate strategies which we believe accurately reflects the treatment options employed by the 
modern paediatric surgeon. 
 
In summary this review demonstrates that use of a PFS results in largely equivalent outcomes 
compared to alternate treatment approaches for infants with gastroschisis. Although planned use of 
a PFS is associated with fewer days on a ventilator such a strategy may expose some infants to 
unnecessary prolonged durations of PN. Further investigation is required to identify not only the 
optimal treatment pathway for infants with gastroschisis which will likely include a case by case 
decision algorithm, but also the tools by which to measure success. 
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Table 1: Description of included studies 
Study Year Study design Multi-
Centre 
Comparative groups and number Exclusions Key findings 
Alali[21] 2011 retrospective review N PFS (34) None reported PFS associated with more 
ventilator days and longer 
duration of PN 
Primary Repair (52) 
Bradnock[14] 2011 prospective national 
cohort study 
Y PFS (99) Complex GS excluded PFS associated with longer TTFF, 
longer duration of PN and 
longer LoS 
Primary Closure (120) 
Charlesworth[12]* 2014 retrospective review N PFS (67) Excluded infants with SBS, 
atresia and gut infarction 
PFS associated with shorter 
ventilation but longer duration 
of PN 
Attempted primary closure (89) 
Chiu[22] 2006 retrospective review N PFS (20) None reported PFS associated with fewer 
complications and lower 
incidence of NEC 
Primary Closure (28) 
Choi[20] 2012 retrospective review N PFS (23) Complex GS excluded No difference in any outcome 
related to method of closure Primary closure without GA (44) 
Fischer[23] 1995 retrospective review N PFS (10) None reported No difference in any outcome 
related to method of closure Primary Closure without GA (25) 
Kidd[24] $ 2003 retrospective review N PFS (53) Co-existing lethal abnormalities 
or complications not related to 
surgical treatment of 
gastroschisis 
Staged closure associated with 
fewer infectious complications 
and compartment syndrome 
but longer length of stay 
Primary closure (27) 
Kimble[25] 2001 prospective cohort 
study 
Y PFS (4) Excluded complex GS and those 
with severe respiratory distress 
Descriptive results only 
Primary Closure without GA (25) 
Lobo[7] 2010 retrospective review N PFS (27) None reported PFS associated with more 
ventilator days Primary Closure (10) 
McNamara[26] 2011 retrospective review N PFS (9) None reported PFS associated with shorter LoS 
(non-significant trend) Primary Closure (8) 
Minkes[16]* 2000 retrospective review N PFS (13) None reported PFS associated with fewer 
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Attempted Primary Closure (30) ventilator days, shorter LoS , 
fewer complications and is 
cheaper 
Owen[18] 2006 retrospective review N PFS (21) Complex GS excluded PFS associated with fewer 
ventilator days Primary closure (27) 
Owen[13] 2010 prospective national 
cohort study 
Y PFS (120) Complex GS excluded from 
outcome analysis 
No difference in any outcome 
related to method of closure Attempted Primary Closure (170) 
Pastor[11]* 2008 prospective  RCT Y PFS (28) <1500g or <34 weeks excluded PFS associated with fewer 
ventilator days (non-significant 
trend) 
Attempted Primary Closure (27) 
Schlatter[5]* 2003 retrospective review N PFS (26) None reported PFS associated with fewer 
ventilator days, shorter TTFF 
and fewer complications.   
Attempted Primary Closure (39) 
Singh[19] 2003 retrospective review Y PFS (30) None reported No difference in any outcome 
related to method of closure Primary Closure (151) 
Skarsgard[15] 2008 contemporaneous 
data collection 
Y PFS (35) None reported PFS associated with longer LoS 
Attempted Primary Closure (55) 
Weil[6] 2012 retrospective review N PFS (147) None reported PFS associated with longer TTFF 
and LoS but fewer ventral 
hernias and wound infections 
Primary Closure (43) 
*= included in 'intention to treat' subgroup analysis; $only data from 1998 onwards included 
GS=gastroschisis; PFS=preformed silo; RCT=randomised controlled trial; TTFF=time to full feeds; PN=parenteral nutrition; LoS=length of stay 
Primary closure' indicates infants who actually had successful primary closure; i.e. infants with failed primary closure with subsequent silo placement are 
not included 
Attempted primary closure includes cases in which primary closure was attempted but was converted to an alternate (e.g. hand-sewn silo, patch repair, 
PFS); non-significant trend indicates a p value of <0.1 but >0.05 
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Table 2 – Results of other outcomes included in this meta-analysis 
Outcome Overall analysis  ‘Intention to treat’ subgroup analysis 
 Studies PFS Alternate Risk Difference p  Studies PFS Alternate Risk Difference p 
Bowel 
ischaemia 
(not NEC) 
3 6/77 3/81 0.03 (-0.04, 0.1) 0.38  1 1/27 1/27 0.00 (-0.1, 0.1) 1.0 
Infectious 
complications 
10 69/434 90/541 0.00 (-0.09, 0.09) 1.05  3 13/66 38/96 0.18 (-0.07, 0.44) 0.16 
NEC 11 37/554 47/534 0.00 (-0.04, 0.04) 0.78  4 13/133 19/185 0.02 (-0.08, 0.11) 0.71 
Unplanned 
re-operation 
7 29/276 54/365 0.06 (-0.05, 0.16) 0.27  2 4/39 16/69 0.14 (0.02, 0.27) 0.03 
Mortality 12 20/534 19/567 0.00 (-0.02, 0.02) 0.82  3 1/120 4/155 0.01 (-0.02, 0.05) 0.45 
Ventral 
hernia 
5 33/224 79/291 0.24 (0.02, 0.53) 0.03  -     
PFS – pre-formed silo 
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Figure 1 – Flowchart of article selection 
 
Figure 2 –- Forest plots of duration of ventilation (days) for the overall analysis (A) and intention to 
treat subgroup analysis (B). Panel C – Forest plot for need for ventilation at any stage. 
 
Figure 3 – Forest plots of duration of parenteral nutrition (top panel, A), time taken to achieve full 
enteral feeds (middle panel, B) and length of hospital stay (bottom panel, C) for the overall analysis. 
 
Figure 4 – Forest plots for the intention-to-treat subgroup analyses showing duration of parenteral 
nutrition (top panel, A), time taken to achieve full enteral feeds (middle panel, B) and length of 
hospital stay (bottom panel, C). 
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Appendix – PRISMA Checklist: 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
22Title  1 Identify the report as a systematic review, meta-
analysis, or both.  
Title 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as 
applicable: background; objectives; data 
sources; study eligibility criteria, participants, and 
interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and 
implications of key findings; systematic review 
registration number.  
1 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the 
context of what is already known.  
2 
Objectives  4 Provide an explicit statement of questions being 
addressed with reference to participants, 
interventions, comparisons, outcomes, and study 
design (PICOS).  
2 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it 
can be accessed (e.g., Web address), and, if 
available, provide registration information 
including registration number.  
N/A 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, 
length of follow-up) and report characteristics 
(e.g., years considered, language, publication 
status) used as criteria for eligibility, giving 
rationale.  
3 
Information sources  7 Describe all information sources (e.g., databases 
with dates of coverage, contact with study 
authors to identify additional studies) in the 
search and date last searched.  
3 
Search  8 Present full electronic search strategy for at least 
one database, including any limits used, such 
that it could be repeated.  
3 
Study selection  9 State the process for selecting studies (i.e., 
screening, eligibility, included in systematic 
review, and, if applicable, included in the meta-
analysis).  
4-5 
Data collection process  10 Describe method of data extraction from reports 
(e.g., piloted forms, independently, in duplicate) 
and any processes for obtaining and confirming 
data from investigators.  
4-5 
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Data items  11 List and define all variables for which data were 
sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
4-5 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias 
of individual studies (including specification of 
whether this was done at the study or outcome 
level), and how this information is to be used in 
any data synthesis.  
8-9 
Summary measures  13 State the principal summary measures (e.g., risk 
ratio, difference in means).  
4-8 
Synthesis of results  14 Describe the methods of handling data and 
combining results of studies, if done, including 
measures of consistency (e.g., I
2
) for each meta-
analysis.  
4-8 
 
 
